Orange County Innovation

Orange County Innovation (OCI) was a medical technology company focused on the development of non-invasive blood constituent monitoring solutions. The company is best known for its work on pulse oximetry and non-invasive hemoglobin monitoring technologies, which aimed to provide clinicians with real-time data without the need for invasive blood draws. OCI's primary innovation was the Pronto-7, a handheld device designed for quick and non-invasive spot-checking of total hemoglobin, SpO2, pulse rate, and perfusion index. The company was acquired by Masimo Corporation in 2011, and its technologies have since been integrated into Masimo's broader portfolio of patient monitoring solutions.